Recently, the National Medical Insurance Administration and the Ministry of Finance jointly issued the "Notice on Prepayment of Medical Insurance Funds" (hereinafter referred to as the "Notice") to further standardize the prepayment system and clarify the scope of use and allocation of prepayments. conditions and expenditure standards, and standardizes the process management, accounting and fund supervision of advance payments. The prepayment system effectively relieves the financial pressure on medical institutions. By allocating medical insurance funds in advance, the prepayment system significantly reduces the cash flow pressure of medical institutions waiting for reimbursement settlement, helps hospitals better manage operating funds, and ensures the continuity and stability of medical services. Prepayments can be used to transfer funds for medical expenses such as the purchase of drugs and medical consumables, allowing hospitals to pay suppliers faster, reducing the pressure on financing in the medical and pharmaceutical industry, and improving the cash flow level of the industry.

The advance payment system will empower the medical and pharmaceutical industries. As the pressure on advance funding is reduced, medical institutions and pharmaceutical companies can invest more funds in R&D and innovation activities to promote the advancement of medical technology and improve the quality of medical services. In addition, the prepayment system helps optimize the allocation of medical resources, improve the efficiency of fund use, and ensure the rational use of medical resources. Prepayment systems can promote medical cost control. The "Notice" stipulates the requirements for regions where prepayments can be paid, prompting each coordinating region to better encourage designated medical institutions to reasonably control medical expenses and ensure the efficient use of medical insurance funds.

Through the prepayment system, unnecessary increases in medical expenses caused by third-party payment are reduced, and principal-agent conflicts between coordinating regional handling agencies and designated medical institutions are reduced. The prepayment system helps improve the quality of medical services. The "Notice" stipulates the conditions for obtaining advance payment, prompting designated medical institutions to improve their financial systems and conduct performance appraisals. Since prepayment payment has requirements for performance appraisal, the prepayment system enables medical institutions to pay more attention to the quality and efficiency of medical services, improve the overall service quality, and ensure that patients receive high-quality medical services.

The prepayment system helps reduce the implementation costs of key medical insurance reforms. The "Notice" requires designated medical institutions that apply for prepayment to actively cooperate in the implementation of key medical insurance reform requirements, which will make the implementation of key medical insurance reforms less costly and improve work efficiency. In short, the full implementation of the prepayment system not only solves the capital flow problem in the medical insurance payment reform, but also promotes the sustainable development of medical institutions and related industries in the pharmaceutical field, and improves the overall level of medical services. Through standardized management, we ensure the safety and rational use of medical insurance funds and achieve a win-win situation for all parties.

https://mp.weixin.qq.com/